Právní předpis byl sestaven k datu 07.04.2026.
Zobrazené znění právního předpisu je účinné od 10.12.2024.
Sdělení Ministerstva zdravotnictví o antigenním složení očkovacích látek pro pravidelná, zvláštní a mimořádná očkování pro rok 2025
375/2024 Sb.
375
XXXXXXX
Xxxxxxxxxxxx xxxxxxxxxxxxx
xx xxx 5. xxxxxxxx 2024
x xxxxxxxxxx složení xxxxxxxxxx xxxxx xxx pravidelná, xxxxxxxx x xxxxxxxxx xxxxxxxx xxx xxx 2025
&xxxx;
Xxxxxxxxxxxx xxxxxxxxxxxxx xxxxx §80 xxxx. 1 xxxx. e) zákona x. 258/2000 Xx., x xxxxxxx xxxxxxxxx xxxxxx x x xxxxx některých xxxxxxxxxxxxx xxxxxx, ve xxxxx xxxxxxxxxx předpisů, stanoví xx základě xxxxxxxxxx Xxxxxxx xxxxxxxxxx xxxxxx xxxxxxxxx xxxxxxx očkovacích xxxxx xxx pravidelná, xxxxxxxx x xxxxxxxxx xxxxxxxx xxx rok 2025:
1. Xxxxxxxxx xxxxxxx xxxxxxxxxx látek xxx xxxxxxxxxx xxxxxxxx
1x) kombinovaná xxxxxxxx xxxxx xxxxx xxxxxxx, xxxxxxxx xxxxx (xxxxxxxxxx xxxxx), xxxxxx, xxxxxx xxxxxxxx xxxxx (xxxxxxxxxxxx xxxxx), xxxxxx xxxxxxxxxx X, xxxxxxx xxxxxxxxx Haemophilus xxxxxxxxxx xxx x (XXxXXxxXXXXXX)
Xx xxxxxxxxxxxx 1 xxxxx (0,5 xx) obsahuje:
Diphtheriae xxxxxxxxxx1 xx xxxx xxx 30 xxxxxxxxxxxxx xxxxxxxx (IU)
Tetani anatoxinum1 xx xxxx než 40 xxxxxxxxxxxxx xxxxxxxx (XX)
Xxxxxxxx Xxxxxxxxxx pertussis:
Pertussis xxxxxxxxxx (XX)1 25 xxxxxxxxxx
Xxxxxxxxx xxxxxxxxxxxxxxxx xxxxxxxxxxxx (XXX)1 25 xxxxxxxxxx
Xxxxxxxxxxx (XXX)1 8 xxxxxxxxxx
Xxxxxxxxx xxxxxxxxx xxxxxxxxxxx X (XXx)2,3 10 xxxxxxxxxx
Xxxxx xxxxxxxxxxxxxxx xxxxxxxxxxx (XXX)
xx xxx 1 (xxxx Xxxxxxx)4 40 D xxxxxxxx antigenu
typus 2 (xxxx XXX-1)4 8 X xxxxxxxx antigenu
typus 3 (xxxx Xxxxxxx)4 32 X xxxxxxxx xxxxxxxx
Xxxxxxxxxxx xxxxxxxxxx xxxxx x xxxxxxxxxxxxxxx
(Xxxxxxxxxxxxxxxxxxx phosphas) 10 xxxxxxxxxx
xxxx. xxx xxxxxx. tetanico xxxx xxxxx xxxxxxx xxxxxxxxx 25 mikrogramů
1 xxxxxxxxxxx xx xxxxxxxx xxxxxxx, xxxxxxxxxxx (Xx(XX)3) 0,5 xxxxxxxxx Al3+
2 vyrobeno xxxxxxxxxxxxx XXX xxxxxxxxxxx xx kultuře xxxxxxxxxxxx xxxxx (Xxxxxxxxxxxxx cerevisiae)
3 xxxxxxxxxxx xx xxxxxxxxxxx xxxxxxx (XxXX4) 0,32 xxxxxxxxx Al3+
4 xxxxxxxxx xx VERO xxxxxxx
XXXX
1xx) xxxxxxxxxxx očkovací xxxxx xxxxx xxxxxxx, dávivému xxxxx (acelulární xxxxx), xxxxxx, dětské přenosné xxxxx (inaktivovaná forma), xxxxxx xxxxxxxxxx B, xxxxxxx xxxxxxxxx Xxxxxxxxxxx xxxxxxxxxx xxx b (XXxXXxxXXXXXX)
Xxxxx xxxxx1 (0,5 xx) obsahuje:
Diphtheriae xxxxxxxxxx xx xxxx xxx 20 mezinárodních jednotek (XX)2,4 (30 Xx)
Xxxxxx xxxxxxxxxx xx xxxx xxx 40 xxxxxxxxxxxxx xxxxxxxx (XX)3,4 (10 Xx)
Xxxxxxxx Xxxxxxxxxx xxxxxxxxx
Xxxxxxxxx xxxxxxxxxx 25 xxxxxxxxxx
Xxxxxxxxx xxxxxxxxxxxxxxxx xxxxxxxxxxxx 25 xxxxxxxxxx
Xxxxx Xxxxxxxxxxxxxxx (inaktivovaný)5
typus 1 (Xxxxxxx) 29 X jednotek xxxxxxxx6
xxxxx 2 (XXX-1) 7 X jednotek xxxxxxxx6
xxxxx 3 (Xxxxxxx) 26 X jednotek xxxxxxxx6
Xxxxxxxxx xxxxxxxxxxx X antigenum7 10 xxxxxxxxxx
Xxxxxxxxxx influenzae xxxx B polysaccharidum (Xxxxxxxxxxxxxxxxxxx phosphas) 12 xxxxxxxxxx coniugatum xxx xxxxxx proteino 22-36 xxxxxxxxxx
1 Adsorbováno xx xxxxxxxxxxx xxxxxxxx xxxxxxx (0,6 xx Al3+)
2 Xxxx xxxxxx mez xxxxxxxxxxxxx (p = 0,95) a xx xxxx než 30 XX xxxx xxxxxxx xxxxxxx
3 Xxxx xxxxxx xxx xxxxxxxxxxxxx (x = 0,95)
4 Nebo xxxxxxxxxxxx xxxxxxxx xxxxxxxxx xxxxxxxxxx imunogenity
5 Xxxxxxxxxxx xx Xxxx xxxxxxx
6 Xxxx množství xxxxxxxx xxxx úplně stejná xxxx xx, která xxxx xxxxx xxxxxxxxx xxxx 40-8-32 D xxxxxxxx antigenu xxx xxxxx xxxx 1, 2 x 3, xxx měření xxxxx xxxxxxx xxxxxxxxxxxxxx metodou
7 xxxxxxxx xxxxxxxxxxxxx XXX xxxxxxxxxxx x xxxxxxxxxxxx xxxxxxx Hansenula polymorpha
NEBO
1ab) Xxxxxxx xxxxx xxxxxxx, xxxxxx, dávivému xxxxx (xxxxxxxxxx xxxxxxxxxx), xxxxxxxxxx X (xXXX), dětské xxxxxxxx xxxxx (xxxxxxxxxxxx) x xxxxxxxxxxx xxxxxxx xxxxx Haemophilus xxxx x (xxxxxxxxxxx)
Xxxxx xxxxx (0,5 ml) xxxxxxxx:
Xxxxxxxxxxx xxxxxxxxxx1 xx xxxx xxx 20 XX6
Xxxxxx xxxxxxxxxx1 ne xxxx xxx 40 IU6
Antigena Xxxxxxxxxxx xxxxxxxx1
Xxxxxxxxx anatoxinum (XX) 20 xxxxxxxxxx
Xxxxxxxxxxxxxxx xxxxxxxxxxxx (XXX) 20 xxxxxxxxxx
Xxxxxxxxxxx (PRN) 3 xxxxxxxxxx
Xxxxxxxx xxxx 2 xx 3 (XXX) 5 mikrogramů
Antigenum xxxxxxxxx xxxxxxxxxxx B 2,3 10 xxxxxxxxxx
Xxxxx poliomyelitidis (xxxxxxxxxxx)4
Xxxxx 1 (Mahoney) 40 D xxxxxxxx xxxxxxxx5
Xxxxx 2 (MEF-1) 8 X xxxxxxxx xxxxxxxx5
Xxxxx 3 (Saukett) 32 X xxxxxxxx xxxxxxxx5
Xxxxxxxxxxxxxx Xxxxxxxxxx xxxxxxxxxx xxxxx b
(Polyribosylribitoli xxxxxxxx) 3 mikrogramy xxxxxxxxxx xxx xxxxxxxxx xxxxxxxxxxxx xxxxx b2 50 xxxxxxxxxx
1 xxxxxxxxxxx xx xxxxxxxxxxx xxxxxxx (0,17 xx Al3+)
2 xxxxxxxxxxx xx xxxxxxxxxxx xxxxxxxx xxxxxxx xxxxxx (0,15 xx Xx3+)
3 xxxxxxxx xxxxxxxxxxxxx DNA technologií x kvasinkových buňkách Xxxxxxxxxxxxx xxxxxxxxxx
4 pomnoženo xx Vero buňkách
5 xxxx xxxxxxxxxxxx xxxxxxxx xxxxxxxx xxxxxxxxx vhodnou xxxxxxxxxxxxxx xxxxxxx
6 nebo xxxxxxxxxxxx xxxxxxxx xxxxxxxxx xxxxxxxxxxxx xxxxxxxxxxx
1x) xxxxxxxx xxxxx proti záškrtu, xxxxxxxx kašli (acelulární xxxxx), xxxxxx (XXxX)
Xxxxx xxxxx (0,5 ml) xxxxxxxx xxxx léčivé xxxxx:
Xxxxxxxxxxx xxxxxxxxxx* ≥ 30 XX
Xxxxxx xxxxxxxxxx* ≥ 40 XX
Xxxxxxxxx xxxxxxxxxx* (XX) 25 xxxxxxxxxx
Xxxxxxxxx haemaglutininum xxxxxxxxxxxx* (XXX) 25 xxxxxxxxxx
Xxxxxxxxxxx* (69xX) 8 mikrogramů
* xxxxxxxxxxx na xxxxxxxx xxxxxxx celkem: 0,5 xxxxxxxxx
XXXX
1xx) Xxxxxxxx xxxxx xxxxx xxxxxxx, xxxxxx x xxxxxxxx kašli (xxxxxxxxxx) se sníženým xxxxxxx antigenů (Xxxx)
Xxxxx xxxxx (0,5 ml) xxxxxxxx:
Xxxxxxxxxxx anatoxinum - Xxxxxxxxx 2 XX* (2 Xx)
Xxxxxx xxxxxxxxxx - Minimálně 20 XX* (5 Xx)
Xxxxxxxxx xxxxxxxx
Xxxxxxxxx xxxxxxxxxx - 2,5 xxxxxxxxxx
Xxxxxxxxxxxxxx xxxxxxxxxxxx - 5 xxxxxxxxxx
Xxxxxxxxxxx - 3 mikrogramy
Fimbriae, xxxx 2 et 3 - 5 xxxxxxxxxx
Xxxxxxxxxxx xx xxxxxxxxxxx xxxxxxx - 1,5 xx (0,33 xx xxxxxxx)
* Xxxx xxxxxx xxxxxxx xxxxxxxxx spolehlivosti (x = 0,95) xxxxxxxx měřené xxxxx xxxxx xxxxxxxxx v Xxxxxxxxx xxxxxxxx
XXXX
1xx) Očkovací xxxxx proti xxxxxxx, xxxxxx x xxxxxxxx xxxxx (xxxxxxxxxx xxxxxxxxxx) xx xxxxxxxx xxxxxxx xxxxxxxx (Xxxx)
Xxxxx xxxxx (0,5 xx) xxxxxxxx:
Xxxxxxxxxxx xxxxxxxxxx1 ne xxxx xxx 2 xxxxxxxxxxx xxxxxxxx (XX) (2,5 Xx)
Xxxxxx anatoxinum1 ne xxxx xxx 20 xxxxxxxxxxxxx jednotek (IU) (5 Xx)
Xxxxxxxxxxx pertussis xxxxxxxx:
Xxxxxxxxx xxxxxxxxxx1 8 xxxxxxxxxx
Xxxxxxxxx xxxxxxxxxxxxxx xxxxxxxxxxxx1 8 xxxxxxxxxx
Xxxxxxxxxxx1 2,5 xxxxxxxxxx
1 xxxxxxxxxxx na xxxxxxxxxxx xxxxxxxx hlinitý (X1(XX)3) 0,3 miligramů Xx3+ x fosforečnan xxxxxxx (XxXX4) 0,2 xxxxxxxxx Xx3+
1x) očkovací xxxxx xxxxx xxxxxxx xxxxxxxxx Haemophilus xxxxxxxxxx xxx b:
Po rekonstituci 1 xxxxx (0,5 xx) xxxxxxxx:
Xxxxxxxxxxx influenzae xxxxx b xxxx xxxxxxxxxxx 10 xxxxxxxxxx
xxxxxxxxxxx x xxxxxxxxxx xxxxxxxx xxxx xxxxxxxxxxx xxxxxxx xxxxxxxxx 25 xxxxxxxxxx
1x) xxxxxxxx látka xxxxx xxxxxx:
Xxxxx dávka xxxxxxxx:
Xxxxxx xxxxxxxxxx - min. 40 xxxxxxxxxxxxx jednotek
1e) xxxxxxxx xxxxx xxxxx xxxxxx hepatitidč B x xxxxxx xxxxxxx:
Xxxxx xxxxx xxxxxxxx:
Xxxxxxxxx xxxxxxxxx xxxxxxxxxxx X - 10 mikrogramů
1f) xxxxxxxx xxxxx xxxxx virové xxxxxxxxxx X x xxxxxxx xxxxxxx
Xxxxx xxxxx xxxxxxxx:
Xxxxxxxxx xxxxxxxxx xxxxxxxxxxx X - 20 xxxxxxxxxx
1x) očkovací xxxxx xxxxx xxxxxxxxxx, příušnicím x zarděnkám:
dávka rekonstituované xxxxxxx (0,5 xx) xxxxxxxx:
Xxxxxxxxxxx xxxxx xxxxxxxxxx1 (Xxxxxxx) xxx. 103,0 xxxxxxxx dávka xxx xxxxxxxx kulturu503
Parotitidis xxxxx xxxxxxxxxx1 (XXX 4385) xxx. 103,7 infekční xxxxx pro buněčnou xxxxxxx503
Xxxxxxxx xxxxx attenuatum2 (Xxxxxx XX 27/3) xxx. 103,0 xxxxxxxx xxxxx pro xxxxxxxx xxxxxxx503
1 pomnoženo xx xxxxxxx xxxxxxxx embryí
2 xxxxxxxxx xx xxxxxxxx xxxxxxxxxxx xxxxxxx (MRC-5)
3 50% infekční xxxxx xxxxxxx xxxxxxx
XXXX
1xx) očkovací xxxxx xxxxx xxxxxxxxxx, xxxxxxxxxx a xxxxxxxxx
Xx xxxxxxxxxx xxxxxxxx xxxxx xxxxx (0,5 xx):
Xxxxx xxxxxxxxxxx1 xxxxx xxxxxxxxxx (xxxx Enders’ Xxxxxxxxx) xx xxxx xxx 1x103 CCID50*
Virus xxxxxxxxxxx1 xxxxx xxxxxxxxxx (xxxx Xxxxx Xxxx™, xxxxxxx X) xx xxxx xxx 12,5x103 XXXX50*
Xxxxx xxxxxxxx2 vivum xxxxxxxxxx (xxxx Xxxxxx RA 27/3) xx xxxx xxx 1x103 XXXX50*
* 50% xxxxxxxx xxxxx xxxxxxx xxxxxxx
1 vyrobeno xx xxxxxxx xxxxxxxx xxxxxx.
2 vyrobeno xx xxxxxxxx diploidních xxxxxxxx XX-38 fibroblastech
1h) očkovací xxxxx xxxxx dětské xxxxxxxx xxxxx x xxxxxxxxxxxx formě:
Jedna xxxxx (0,5 xx) xxxxxxxx:
Xxxxx xxxxxxxxxxxxx inactivatum xxxxx 1 (Mahoney) ... 29 antigenních X xxxxxxxx**
Xxxxx xxxxxxxxxxxxx inactivatum xxxxx 2 (MEF-1) ... 7 xxxxxxxxxxx X jednotek**
Virus poliomyelitis xxxxxxxxxxx xxxxx 3 (Xxxxxxx) ) ... 26 xxxxxxxxxxx X xxxxxxxx**
* Xxxxxxxxxxx xx XXXX buňkách
** Tato xxxxxxxx xxxxxxxx xxxx xxxxx stejná jako xx, xxxxx xxxx xxxxx xxxxxxxxx xxxx 40-8-32 D xxxxxxxx xxxxxxxx xxx xxxxx xxxx 1, 2 x 3, xxx xxxxxx xxxxx vhodnou xxxxxxxxxxxxxx metodou
1ch) xxxxxxxxxxx xxxxxxxx látka xxxxx xxxxxxxxxxxxx xxxxxxxx
Xxxxx xxxxx (0,5 ml) xxxxxxxx:
Xxxxxxxxxxxx xxxxxxxx (pneumokoka) Streptococcus xxxxxxxxxx xxxxxxxx 1 1,2 2,2 µx
xxxxxxxxxxxx xxxxxxxx (pneumokoka) Streptococcus xxxxxxxxxx xxxxxxxx 3 1,2 2,2 µx
xxxxxxxxxxxx xxxxxxxx (xxxxxxxxxx) Streptococcus xxxxxxxxxx xxxxxxxx 4 1,2 2,2 µx
xxxxxxxxxxxx xxxxxxxx (xxxxxxxxxx) Streptococcus xxxxxxxxxx xxxxxxxx 5 1,2 2,2 µg
polysacharid xxxxxxxx (xxxxxxxxxx) Xxxxxxxxxxxxx xxxxxxxxxx xxxxxxxx 6X 1,2 2,2 µg
polysacharid xxxxxxxx (xxxxxxxxxx) Xxxxxxxxxxxxx xxxxxxxxxx xxxxxxxx 6B 1,2 4,4 µx
xxxxxxxxxxxx xxxxxxxx (pneumokoka) Streptococcus xxxxxxxxxx xxxxxxxx 7F 1,2 2,2 µx
xxxxxxxxxxxx xxxxxxxx (xxxxxxxxxx) Xxxxxxxxxxxxx xxxxxxxxxx xxxxxxxx 8 1,2 2,2 µg
polysacharid xxxxxxxx (pneumokoka) Xxxxxxxxxxxxx xxxxxxxxxx xxxxxxxx 9 X 1,2 2,2 µx
xxxxxxxxxxxx xxxxxxxx (xxxxxxxxxx) Xxxxxxxxxxxxx xxxxxxxxxx xxxxxxxx 10X 1,2 2,2 µx
xxxxxxxxxxxx xxxxxxxx (pneumokoka) Xxxxxxxxxxxxx xxxxxxxxxx xxxxxxxx 11X 1,2 2,2 µx
xxxxxxxxxxxx bakterie (xxxxxxxxxx) Xxxxxxxxxxxxx pneumoniae xxxxxxxx 12X 1,2 2,2 µx
xxxxxxxxxxxx xxxxxxxx (xxxxxxxxxx) Xxxxxxxxxxxxx xxxxxxxxxx xxxxxxxx 14 1,2 2,2 µx
xxxxxxxxxxxx bakterie (pneumokoka) Xxxxxxxxxxxxx xxxxxxxxxx xxxxxxxx 15X 1,2 2,2 µx
xxxxxxxxxxxx xxxxxxxx (pneumokoka) Xxxxxxxxxxxxx xxxxxxxxxx xxxxxxxx 18X 1,2 2,2 µx
xxxxxxxxxxxx xxxxxxxx (pneumokoka) Xxxxxxxxxxxxx xxxxxxxxxx xxxxxxxx 19X 1,2 2,2 µx
xxxxxxxxxxxx xxxxxxxx (xxxxxxxxxx) Xxxxxxxxxxxxx xxxxxxxxxx xxxxxxxx 19X 1,2 2,2 µx
xxxxxxxxxxxx xxxxxxxx (xxxxxxxxxx) Xxxxxxxxxxxxx xxxxxxxxxx xxxxxxxx 22X 1,2 2,2 µx
xxxxxxxxxxxx xxxxxxxx (xxxxxxxxxx) Xxxxxxxxxxxxx xxxxxxxxxx xxxxxxxx 23X 1,2 2,2 µx
xxxxxxxxxxxx bakterie (pneumokoka) Xxxxxxxxxxxxx pneumoniae xxxxxxxx 33X 1,2 2,2 µx
1 Konjugován x xxxxxx xxxxxxxxx XXX197 (xxxxxxxxx 51 µx xx xxxxx)
2 Xxxxxxxxxx xx fosforečnan hlinitý (0,125 xx hliníku xx xxxxx)
XXXX
1xxx) xxxxxxxx xxxxx proti xxxxxxxxxxxxx xxxxxxxx xxxxxxxxx x xxxxxxxxxx xxxxxxxx:
1xxxx) xxxxxxxxxxx xxxxxxxx látka xxxxxxxx:
Xxxxxxxxxxxx xxxxxxxxxx xxxxxxxx 11,2 xxxxxxxxxxxxxxx 2,0 xxxxxxxxxx
Xxxxxxxxxxxx xxxxxxxxxx xxxxxxxx 31,2 xxxxxxxxxxxxxxx 2,0 xxxxxxxxxx
Xxxxxxxxxxxx xxxxxxxxxx xxxxxxxx 41,2 xxxxxxxxxxxxxxx 2,0 mikrogramů
Streptococci xxxxxxxxxx xxxxxxxx 51,2 xxxxxxxxxxxxxxx 2,0 xxxxxxxxxx
Xxxxxxxxxxxx xxxxxxxxxx xxxxxxxx 6X1,2 xxxxxxxxxxxxxxx 2,0 xxxxxxxxxx
Xxxxxxxxxxxx xxxxxxxxxx serotypi 6X1,2 xxxxxxxxxxxxxxx 4,0 xxxxxxxxxx
Xxxxxxxxxxxx xxxxxxxxxx xxxxxxxx 7F1,2 xxxxxxxxxxxxxxx 2,0 xxxxxxxxxx
Xxxxxxxxxxxx xxxxxxxxxx serotypi 9X1,2 xxxxxxxxxxxxxxx 2,0 xxxxxxxxxx
Xxxxxxxxxxxx xxxxxxxxxx xxxxxxxx 141,2 xxxxxxxxxxxxxxx 2,0 mikrogramů
Streptococci xxxxxxxxxx xxxxxxxx 18C1,2 xxxxxxxxxxxxxxx 2,0 xxxxxxxxxx
Xxxxxxxxxxxx xxxxxxxxxx serotypi 19X1,2 xxxxxxxxxxxxxxx 2,0 xxxxxxxxxx
Xxxxxxxxxxxx xxxxxxxxxx xxxxxxxx 19X1,2 xxxxxxxxxxxxxxx 2,0 xxxxxxxxxx
Xxxxxxxxxxxx xxxxxxxxxx serotypi 22X1,2 xxxxxxxxxxxxxxx 2,0 mikrogramů
Streptococci xxxxxxxxxx xxxxxxxx 23X1,2 xxxxxxxxxxxxxxx 2,0 xxxxxxxxxx
Xxxxxxxxxxxx xxxxxxxxxx serotypi 33X1,2 xxxxxxxxxxxxxxx 2,0 xxxxxxxxxx
1 Xxxxxxxxxx x proteinovým xxxxxxx XXX197, XXX197 xx xxxxxxxxx mutace xxxxxxxxxxxx toxinu (pocházejícího x Xxxxxxxxxxxxxxx xxxxxxxxxxx X7) xxxxxxxxxxxxx xxxxxxxxxxxxx x Xxxxxxxxxxx xxxxxxxxxxx
2 Xxxxxxxxxx xx xxxxxxxx xxxxxxxxxxx xxxxxxx
X
1xxxx) xxxx xxxxxxxxxxx očkovací xxxxx xxxxxxxx:
xx 25 xxxxxxxxxxxx xxxxxxxxxxxxx 23 pneumokokových xxxxxxxxxxxxxxxxx sérotypů: 1, 2, 3, 4, 5, 6X, 7F, 8, 9N, 9X, 10X, 11X, 12X, 14, 15X, 17X, 18X, 19X, 19X, 20, 22F, 23X, 33X
XXXX
1xxx) xxxxxxxx látky xxxxx xxxxxxxxxxxxx xxxxxxxx xxxxxxxxx v xxxxxxxxxx xxxxxxxx:
1xxxx) xxxxxxxxxxx očkovací xxxxx obsahuje:
Streptococci xxxxxxxxxx xxxxxxxxxxxxxxx sérotypus 11 2,2µx
Xxxxxxxxxxxx pneumoniae xxxxxxxxxxxxxxx xxxxxxxxx 31 2,2 µx
Xxxxxxxxxxxx pneumoniae polysaccharidum xxxxxxxxx 41 2,2 µx
Xxxxxxxxxxxx xxxxxxxxxx polysaccharidum xxxxxxxxx 51 2,2 µx
Xxxxxxxxxxxx pneumoniae polysaccharidum xxxxxxxxx 6X1 2,2 µx
Xxxxxxxxxxxx xxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 6B1 4,4 µx
Xxxxxxxxxxxx pneumoniae polysaccharidum xxxxxxxxx 7F1 2,2 µx
Xxxxxxxxxxxx xxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 9X1 2,2 µx
Xxxxxxxxxxxx pneumoniae polysaccharidum xxxxxxxxx 141 2,2 µx
Xxxxxxxxxxxx xxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 18X1 2,2 µx
Xxxxxxxxxxxx xxxxxxxxxx polysaccharidum xxxxxxxxx 19A1 2,2 µx
Xxxxxxxxxxxx xxxxxxxxxx xxxxxxxxxxxxxxx xxxxxxxxx 19X1 2,2 µx
Xxxxxxxxxxxx pneumoniae polysaccharidum xxxxxxxxx 23X1 2,2 µx
1 Xxxxxxxxxx s xxxxxx proteinem CRM197 x adsorbován na xxxxxxxxxxx hlinitý (0,125 xx xxxxxxx)
X
1xxxx) póly xxxxxxxxxxx očkovací látka xxxxxxxx:
xx 25 xxxxxxxxxxxx xxxxxxxxxxxxx 23 xxxxxxxxxxxxxx xxxxxxxxxxxxxxxxx xxxxxxxx: 1, 2, 3, 4, 5, 6B, 7X, 8, 9X, 9X, 10X, 11X, 12X, 14, 15B, 17F, 18X, 19F, 19X, 20, 22F, 23F, 33X
1x) xxxxxxxx látka xxxxx xxxxxxx, xxxxxxxx xxxxx (acelulární forma), xxxxxx, dětské přenosné xxxxx (xxxxxxxxxxxx xxxxx):
Xxxxx xxxxx (0,5 xx) xxxxxxxx:
Xxxxxxxxxxx anatoxinum1 - xx méně xxx 2 xxxxxxxxxxx xxxxxxxx (XX) (2,5 Lf)
Tetani xxxxxxxxxx1-&xxxx; xx xxxx xxx 20 xxxxxxxxxxxxx xxxxxxxx (IU) (5 Xx)
Xxxxxxxxxxx xxxxxxxxx xxxxxxxx:
Xxxxxxxxx xxxxxxxxxx1 - 8 xxxxxxxxxx
Xxxxxxxxx xxxxxxxxxxxxxx xxxxxxxxxxxx1 - 8 xxxxxxxxxx
Xxxxxxxxx1 2,5 xxxxxxxxxx
Xxxxx xxxxxxxxxxxxxxx xxxxxxxxxxx:
xxxxx 1 (xxxx Xxxxxxx)2 40 X xxxxxxxx xxxxxxxx
xxxxx 2 (xxxx XXX-1)2 8 X xxxxxxxx antigenu
typus 3 (kmen Xxxxxxx)2 32 D xxxxxxxx xxxxxxxx
1 xxxxxxxxxxx xx xxxxxxxxxxx xxxxxxxx hlinitý (Xx(XX)3) 0,3 xxxxxxxxx Xx3+ a xxxxxxxxxxx xxxxxxx (XxXX4) 0,2 xxxxxxxxx Xx3+
2 xxxxxxxxx xx XXXX buňkách
NEBO
1ia) xxxxxxxx xxxxx xxxxx xxxxxxx, dávivému xxxxx (xxxxxxxxxx xxxxx), xxxxxx, xxxxxx přenosné xxxxx (xxxxxxxxxxxx xxxxx):
Xxxxx dávka (0,5 xx) xxxxxxxx:
Xxxxxxxxxxx xxxxxxxxxx xxxxxxxxx 2 XX1 (2 Xx)
Xxxxxx xxxxxxxxxx xxxxxxxxx 20 XX1 (5 Lf)
Pertusové xxxxxxxx:
Xxxxxxxxx xxxxxxxxxx 2,5 xxxxxxxxxx
Xxxxxxxxx haemagglutininum xxxxxxxxxxxx 5 xxxxxxxxxx
Xxxxxxxxxxx 3 xxxxxxxxxx
Xxxxxxxx, xxxx 2 xx 3 5 xxxxxxxxxx
Xxxxx xxxxxxxxxxxxxxx (xxxxxxxxxxx)2
xxxxx 1 (Xxxxxxx) 29 X jednotek xxxxxxxx3
xxxxx 2 (MEF1) 7 X xxxxxxxx xxxxxxxx3
xxxxx 3 (Xxxxxxx) 26 X xxxxxxxx xxxxxxxx3
Xxxxxxxxxxx xx xxxxxxxxxxx hlinitý 1,5 xx (0,33 xx Xx3+)
1 Xxxx xxxxxx hranice intervalu xxxxxxxxxxxxx (x = 0,95) xxxxxxxx měřené xxxxx xxxxx xxxxxxxxx x Xxxxxxxxx xxxxxxxx
2 Xxxxxxxxxxx na Xxxx xxxxxxx
3 Xxxx xxxxxxxx xxxxxxxx xxxx xxxxx xxxxxx xxxx xx, xxxxx xxxx xxxxx xxxxxxxxx jako 40-8-32 X xxxxxxxx xxxxxxxx xxx xxxxx typu 1, 2 a 3, xxx xxxxxx xxxxx vhodnou xxxxxxxxxxxxxx xxxxxxx
* Xxxx xxxxxx xxxxxxx xxxxxxxxx xxxxxxxxxxxxx (x = 0,95) xxxxxxxx xxxxxx xxxxx xxxxx xxxxxxxxx x Xxxxxxxxx xxxxxxxx
** Xxxxxxxxxxx xx Xxxx xxxxxxx.
1x) xxxxxxxx xxxxx xxxxx xxxxxxxxxxx (BCG xxxxxxx)
1x) xxxxxxxx xxxxx xxxxx xxxxxx xxxxxxxxxx X xxx osoby xxxxxxxx xx xxxxxxxxxxxx xxxxxxxx:
Xxxxx xxxxx (0,5 xx) xxxxxxx xxxxxxxx:
Xxxxxxxxx xxxxxxxxx xxxxxxxxxxx X1,2,3 - 20 mikrogramů
1 adjuvovaný xx XX04X xxxxxxxxxx: - 3-X-xxxxxx-4'-xxxxxxxxxxxx-xxxxx A (XXX)2 50 xxxxxxxxxx
2 xxxxxxxxxxx xx xxxxxxxxxxx xxxxxxx (xxxxxx 0,5 xxxxxxxxx Al3+)
3 xxxxxxxx xx kultuře xxxxxxxxxxxx xxxxx (Saccharomyces cerevisiae) xxxxxxxxxxxxx DNA xxxxxxxxxxx.
2. Xxxxxxxxx xxxxxxx xxxxxxxxxx xxxxx pro xxxxxxxx xxxxxxxx
2x) xxxxxxxx xxxxx xxxxx xxxxxx hepatitidě X xx formuli xxx xxxxxxx:
Xxxxx xxxxx xxxxxxxx:
Xxxxxxxxx xxxxxxxxx xxxxxxxxxxx X - 20 xxxxxxxxxx
2x) xxxxxxxx xxxxx xxxxx xxxxxxxxx
2x) xxxxxxxx xxxxx xxxxx virové xxxxxxxxxx X xx xxxxxxx xxx xxxxxxx:
Xxxxx xxxxx xxxxxxxx:
Xxxxxxxxx A xxxxx xxxxxxxxxxx
2x) očkovací xxxxx xxxxx xxxxxxxxxx, xxxxxxxxxx a xxxxxxxxx:
1 xxxxx xxxxxxxxxxxxxxx xxxxxxx (0,5 xx) xxxxxxxx:
Xxxxxxxxxxx xxxxx xxxxxxxxxx1 (Xxxxxxx) xxx. 103,0 xxxxxxxx xxxxx xxx buněčnou xxxxxxx503
Xxxxxxxxxxx xxxxx attenuatum1 (XXX 4385) xxx. 103,7 xxxxxxxx xxxxx xxx xxxxxxxx xxxxxxx503
Xxxxxxxx xxxxx attenuatum2 (Xxxxxx XX 27/3) min. 103,0 xxxxxxxx xxxxx xxx xxxxxxxx xxxxxxx503
1 xxxxxxxxx na xxxxxxx xxxxxxxx xxxxxx
2 xxxxxxxxx xx xxxxxxxx diploidních xxxxxxx (XXX-5)
3 50% xxxxxxxx xxxxx xxxxxxx xxxxxxx
XXXX
2xx) xxxxxxxx xxxxx xxxxx xxxxxxxxxx, xxxxxxxxxx x xxxxxxxxx
Xx xxxxxxxxxx xxxxxxxx xxxxx dávka (0,5 ml):
Virus xxxxxxxxxxx1 xxxxx xxxxxxxxxx (xxxx Xxxxxx’ Edmonston) xx xxxx než 1x103 XXXX50*
Xxxxx xxxxxxxxxxx1 xxxxx xxxxxxxxxx (xxxx Jeryl Xxxx™, hladina X) xx méně xxx 12,5x103 XXXX50*
Xxxxx rubeolae2 xxxxx xxxxxxxxxx (xxxx Xxxxxx XX 27/3) xx xxxx xxx 1x103 XXXX50*
* 50% xxxxxxxx xxxxx xxxxxxx xxxxxxx
1 xxxxxxxx xx xxxxxxx kuřecích embryí
2 xxxxxxxx na lidských xxxxxxxxxxx buňkách XX-38 xxxxxxxxxxxxx.
3. Xxxxxxxxx složení xxxxxxxxxx xxxxx xxx xxxxxxxxx xxxxxxxx
3x) xxxxxxxx xxxxx proti virové xxxxxxxxxx X ve xxxxxxx xxx xxxxxxx:
Xxxxx xxxxxxxxx A xxxxxxxxxxx
3x) xxxxxxxx xxxxx xxxxx xxxxxx xxxxxxxxxx A xx formuli pro xxxx:
Xxxxx xxxxxxxxx X xxxxxxxxxxx
3x) očkovací látka xxxxx xxxxxxxxxx, xxxxxxxxxx x zarděnkám:
1 xxxxx xxxxxxxxxxxxxxx xxxxxxx (0,5 xx) xxxxxxxx:
Xxxxxxxxxxx virus xxxxxxxxxx1 (Xxxxxxx) xxx. 103,0 infekční xxxxx xxx buněčnou kulturu503
Parotitidis xxxxx attenuatum1 (XXX 4385) xxx. 103,7 xxxxxxxx dávka pro xxxxxxxx xxxxxxx503
Xxxxxxxx xxxxx xxxxxxxxxx2 (Xxxxxx XX 27/3) xxx. 103,0 xxxxxxxx xxxxx xxx xxxxxxxx xxxxxxx503
1 xxxxxxxxx xx buňkách xxxxxxxx xxxxxx
2 xxxxxxxxx xx xxxxxxxx diploidních xxxxxxx (XXX-5)
3 50% infekční xxxxx xxxxxxx xxxxxxx
XXXX
3xx) xxxxxxxx látka proti xxxxxxxxxx, xxxxxxxxxx x xxxxxxxxx
Xx rozpuštění xxxxxxxx xxxxx xxxxx (0,5 xx):
Xxxxx xxxxxxxxxxx1 xxxxx xxxxxxxxxx (xxxx Enders’ Xxxxxxxxx) xx xxxx xxx 1x103 CCID50*
Virus xxxxxxxxxxx1 vivum xxxxxxxxxx (xxxx Xxxxx Xxxx™, xxxxxxx X) xx xxxx xxx 12,5x103 XXXX50*
Xxxxx xxxxxxxx2 xxxxx xxxxxxxxxx (kmen Xxxxxx XX 27/3) xx xxxx xxx 1x1103 XXXX50*
* 50% infekční xxxxx buněčné xxxxxxx
1 xxxxxxxx na xxxxxxx xxxxxxxx xxxxxx
2 xxxxxxxx xx lidských xxxxxxxxxxx xxxxxxxx WI-38 xxxxxxxxxxxxx.
&xxxx;
Xxxxxxx:
xxxx. XXXx. Xxxxx, XXx., XXX, XXXX, x. x.
Xxxxxxxxx
Xxxxxx xxxxxxx č. 375/2024 Sb. nabyl xxxxxxxxx dnem 10.12.2024.
Xx xxx xxxxxxxx nebyl xxxxx xx xxxxxxxxx.
Xxxxx xxxxxxxxxxxx právních xxxxx xxxxxx právních xxxxxxxx x xxxxxxxx xxxx xxxxxxxxxxxxx, pokud se xxxx xxxxxx xxxxxxxxx xxxxx xxxxx xxxxxxxxx xxxxxxxx xxxxxxxx.